Los Altos Hills, CA, United States of America

John Brian Mumm

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: John Brian Mumm: Innovator in Immunology

Introduction

John Brian Mumm is a prominent inventor based in Los Altos Hills, California. He has made significant contributions to the field of immunology, particularly in the development of therapeutic methods for treating diseases. With a total of 13 patents to his name, Mumm's work has the potential to impact the treatment of various immune-related disorders.

Latest Patents

Mumm's latest patents include groundbreaking methods for the production of antigen-specific CD8+ T cells. These methods involve isolating CD8+ T cells that express a disease antigen-specific T cell receptor. The patents also cover therapeutic methods for administering these isolated CD8+ T cells to subjects, as well as genetically modifying them to express disease antigen-specific T cell receptors or chimeric antigen receptors. Additionally, he has developed methods for using interleukin-10 to treat diseases, including cancer and inflammatory disorders, by combining it with other agents.

Career Highlights

Throughout his career, John Brian Mumm has worked with notable companies such as Armo Biosciences, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the medical field.

Collaborations

Mumm has collaborated with esteemed colleagues, including Martin Oft and Ivan Ho Chan. These partnerships have further enriched his research and development efforts in immunology.

Conclusion

John Brian Mumm is a distinguished inventor whose work in immunology has led to significant advancements in therapeutic methods for treating diseases. His contributions continue to shape the future of medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…